
Taiwan NHI excludes coverage for new Alzheimer's drug Kisunla
Taipei, July 31 (CNA) Kisunla, a newly approved Alzheimer's drug in Taiwan, will not be covered by the National Health Insurance (NHI) system, while coverage for Leqembi, another Alzheimer's treatment approved this year, is still under review, a …